Effect of Cenicriviroc on HIV Neurocognitive Impairment

Phase 2 Completed 20 enrolled University of Hawaii Tobira Therapeutics, Inc. · collab

NaSingle-groupOpen-labelTreatment

Summary

The study hypothesis is that cenicriviroc will improve cognition in HIV infected individuals with cognitive impairment. The investigators will study the effect of cenicriviroc on cognition in 24 subjects over a 24 week period.

Timeline

Start: 2014-04
Primary completion: 2016-06
Completion: 2016-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cenicriviroc	Small molecule	50 mg	—

Effect of Cenicriviroc on HIV Neurocognitive Impairment

Summary

Timeline

Drugs

Indications